Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for VERFAHREN ZUR REDUZIERUNG DES LIPOPROTEIN (A)-SPIEGELS DURCH VERABREICHUNG EINES INHIBITORS DER PROPROTEINKONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Details for 2019162319
Up to date per 09.06.2026
Actions
Details for 2019162319
Title / Product Name
VERFAHREN ZUR REDUZIERUNG DES LIPOPROTEIN (A)-SPIEGELS DURCH VERABREICHUNG EINES INHIBITORS DER PROPROTEINKONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019162319
EP Publication Number
3536712
E-Number
1570894
Language
EN
PCT Number
Publication Date
11.09.2019 A
31.05.2023 B1
Registration Date
31.05.2023
AT Publication Date
15.06.2023
Application Date
12.09.2012
Registration Number
-
Priorities
16.09.2011
US
201161535392 P
14.11.2011
US
201161559162 P
02.05.2012
US
201261641321 P
IPC
C07K 16/40 20060101AFI20230301BHEP
Maximum Duration of Protection
12.09.2032
Owner
Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591-6706US
Representative
No representatives present
Inventor
SWERGOLD,, Gary75 Sheldrake Place New Rochelle, NY 10804US